Iphytoral 100mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent effective against a variety of fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and localized fungal infections, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Iphytoral is administered orally, with absorption enhanced when taken with food to maximize bioavailability. The dosage and duration of therapy depend on the severity and type of infection, and treatment should be guided by clinical response and microbiological findings. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and rash. Iphytoral should be used cautiously in patients with hepatic impairment due to the risk of hepatotoxicity, and liver function tests should be monitored periodically during prolonged therapy. It is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals and in those receiving certain medications that may interact adversely. This medication should be prescribed and used under strict medical supervision to ensure safety and efficacy.